Novartis's total assets for Q1 2025 were $99.94B, a decrease of -2.25% from the previous quarter. NVS total liabilities were $61.49B for the fiscal quarter, a 5.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.